Department of Pediatrics
University of California, USA
Dr Ankita Garg is in School of Medicine at University of California San Diego and investigating the role of myeloid derived suppressor cells mediated immune suppression in HIV-1 infection. She earned Ph.D. from SGPGIMS, India for her work on understanding molecular mechanism of Ethambutol resistance in Mycobacterium tuberculosis and immune pathogenesis of ethambutol resistant M tuberculosis strain. During postdoctoral research at UTHCT Texas, Dr Garg studied the role of natural killer and regulatory T cells in M tuberculosis infection. She has served as Senior Research Scientist in R&D Division of Panacea Biotec and Lupin Ltd, two well-established drug discovery and development organizations. She was responsible for rationalized selection of targets and enriching the discovery pipeline including drug discovery, in-vitro and in-vivo assays, cross-functions such as DMPK, toxicology for diverse therapeutic areas. Dr Garg has over nine years of experience in translational research pertaining to infectious disease and immune disorders.
Mycobacterium tuberculosis, immune dysfunction in HIV-AIDS and associated co infections, cellular and clinical immunology, translational immunology, biomarkers, vaccine research